omniture
logo
Search
浙江三叶草生物制药有限公司 CLOVERBIOPHARMA
Media Room

Latest News

rss

Clover's COVID-19 Vaccine Candidate Demonstrates 79% Efficacy Against Delta in Global Phase 2/3 SPECTRA Trial Dominated by Variants of Concern and Interest

* Trial enrolled over 30,000 adult & elderly participants across 4 continents; 100% of SARS-CoV-2...

2021-09-22 18:56 2847
Clover's COVID-19 Vaccine Candidate Demonstrates 79% Efficacy Against Delta in Global Phase 2/3 SPECTRA Trial Dominated by Variants of Concern and Interest

Clover Biopharmaceuticals Receives Pharmaceutical Manufacturing Permit from Zhejiang Medical Products Administration to Produce COVID-19 Vaccine

CHENGDU, China, Sept. 9, 2021 /PRNewswire/ -- Clover Biopharmaceuticals, Ltd. (Clover)

2021-09-09 19:51 3155

Clover Biopharmaceuticals Completes Enrollment of Adult and Elderly Population in SPECTRA Global Phase 2/3 Clinical Trial for its COVID-19 Vaccine Candidate

* SPECTRA enrolled over 29,000 adult and elderly participants across four continents achieving hi...

2021-07-06 14:00 3609

Clover and Dynavax Announce Commercial Supply Agreement of Dynavax's CpG 1018 Adjuvant for Clover's COVID-19 Vaccine Candidate

* Clover to procure CpG 1018 adjuvant from Dynavax for use in the commercial production of Clover...

2021-06-30 16:00 6251

Clover Announces Advance Purchase Agreement with Gavi for Over 400 Million Doses of Clover's COVID-19 Vaccine for the COVAX Facility

* Pending WHO EUL for its COVID-19 vaccine candidate, Clover is committed to providing 64 million...

2021-06-30 16:00 3270